October 18, 2022

BioSkryb Genomics and Cooper Surgical Ink Multi-Year Deal to Accelerate Clinical Discovery and Diagnostics in Women’s Reproductive Health

New partnership brings transformative, high-resolution single-cell genomic technology to the field of preimplantation genetic testing in the pursuit of improved discovery and clinical outcomes.

DURHAM, N.C., October 18, 2022 – BioSkryb Genomics, a pioneer in developing scientifically advanced single…

September 21, 2022

BioXpedia A/S and BioSkryb Genomics Announce European Partnership to Provide Groundbreaking, Single-Cell, Multiomic Analysis for Novel Target Identification and Therapeutic Development

This new partnership brings high-resolution, single-cell whole genome and whole transcriptome analysis to Europe. This partnership will enable novel insights and deep cellular characterization required in the evaluation, creation, and validation of new generation biologics and therapeutics in target…

May 31, 2022

BioSkryb Genomics Launches ResolveOME Early Access Program for Full Genome and Transcriptome Amplification from a Single Cell, in Conjunction with Its Innovative Bioinformatics Platform, BaseJumper™

DURHAM, N.C., May 31, 2022--(BUSINESS WIRE)--BioSkryb Genomics, a biotech company developing advanced single-cell analysis tools, today announced the launch of the Early Access Program (EAP) for ResolveOME, a unified, single-cell workflow that amplifies the complete genome and full-length mRNA …

February 9, 2022

BioSkryb Genomics and ALS Automated Lab Solutions GmbH Sign U.S. Distribution Agreement to Power Unprecedented Single Cell Spatial Genomics

DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb Genomics, a leader of single-cell genome amplification, and ALS Automated Lab Solutions GmbH, developers of a multi-patented spatial single cell and colony picking technology platform, today announced a U.S. distribution agreement to power comprehensive s…

October 12, 2021

BioSkryb Completes Move into New Global Headquarters in Durham, N.C.

Move supports company’s multi-year strategic growth initiative; advances retention, attraction, and expansion of the team; enhances the ability to serve customers; and demonstrates Company's commitment to the region

DURHAM, N.C., October 12, 2021 – BioSkryb Genomics, Inc., today announced the reloca…

August 16, 2021

Meet BioSkryb’s New Commercial Team Members Providing Customer Care and Technical Support

We are excited to welcome three new team members who bring deep scientific knowledge as well as technical experience in supporting researcher needs in applying new genomic and molecular biology solutions.

“Just as we know each cell is unique, so are our people,” said Jay West, Ph.D., CEO and cofoun…

August 4, 2021

In-depth empowerment and innovation! 2021 MGI & IDG Capital Life and Health Acceleration Camp officially opens

JULY 31 - HUATAI ZHI MADE (MGI), IDG INVESTMENT INNOVATION INSTITUTE AND BLUE RAINBOW LIFE SCIENCES ACCELERATOR JOINTLY ORGANIZED BY THE MGI & IDG CAPITAL ACCELERATED LIFE AND HEALTH BUSINESS (HEREINAFTER REFERRED TO AS "ACCELERATED CAMP") IN THE NANSHAN DISTRICT, SHENZHEN, IDG CAPITAL INNOVATION TH…

June 30, 2021

BioSkryb Appoints Gary Harton, Ph.D., Chief Scientific Officer

Dr. Harton to lead the translation of BioSkryb’s Primary Template-directed Amplification (PTA) technology into breakthrough diagnostic applications for targeted indications, including cancer and neurological disorders

DURHAM, N.C., June 30, 2021 -- BioSkryb, Inc., today announced the expansion of th…

April 21, 2021

BioSkryb Appoints Sean Keohane Senior Vice President of Commercial Operations

DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., today announced the expansion of the company’s leadership team with the appointment of Sean Keohane as Senior Vice President of Commercial Operations. Keohane has more than 25 years of experience in life science product commercialization, with demonstrate…

March 10, 2021

Top 10 BioTech Industry Trends & Innovations in 2021

The BioTech industry is adopting trends like artificial intelligence (AI), data analytics, and automation to optimize production. Consequently, there has been a rise in consumer BioTech or BioTech products targeted directly at customers instead of biopharma or healthcare businesses. While the indust…